A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/675 (2006.01) A61K 31/513 (2006.01) A61K 31/7076 (2006.01) A61K 45/06 (2006.01)
Patent
CA 2512319
The present invention relates to therapeutic combinations of [9-[R-2-[[(S)- [[(S)-1-(isopropoxycarbonyl)ethyl]amino]- phenoxyphosphinyl]methoxy]propyl]adenine(GS-7340) and (2R, 5S, cis)-4-amino-5- fluoro-1-(2-hydroxymethyl-1,3-oxathiolan-5-yl)-(1H)-pyrimidin-2-one (emtricitabine,(-)-cis FTC, EmtrivaTM and their physiologically functional derivatives. The combinations may be useful in the treatment of HIV infections, including infections with HIV mutants bearing resistance to nucleoside and/or non-nucleoside inhibitors. The present invention is also concerned with pharmaceutical compositions and formulations of said combinations of GS-7340 and emtricitabine, and their physiologically functional derivatives, as well as therapeutic methods of use of those compositions and formulations.
La présente invention concerne des combinaisons thérapeutiques de [9-[<I>R</I>-2-[[(<I>S</I>)-[[(<I>S</I>)-1-(isopropoxycarbonyl)éthyl]amino]-phénoxyphosphinyl]méthoxy]propyl]adénine (GS-7340) et de (2<I>R</I>, 5<I>S</I>, cis)-4-amino-5-fluoro-1-(2-hydroxyméthyl-1,3-oxathiolan-5-yl)-(1H)-pyrimidin-2-one (emtricitabine,(-)-cis FTC, Emtriva<SP>TM</SP>) et leurs dérivés physiologiquement fonctionnels. Ces combinaisons peuvent être utiles dans le traitement d'infections à VIH, y compris d'infections par des mutants du VIH résistants à des inhibiteurs nucléosidiques et/ou non nucléosidiques. Ladite invention concerne également des compositions et formulations pharmaceutiques desdites combinaisons de GS-7340 et d'emtricitabine, et leurs dérivés physiologiquement fonctionnels, ainsi que des méthodes thérapeutiques d'utilisation desdites compositions et formulations.
Dahl Terrence C.
Menning Mark M.
Oliyai Reza
Gilead Sciences Inc.
Robic
LandOfFree
Compositions and methods for combination antiviral therapy does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions and methods for combination antiviral therapy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions and methods for combination antiviral therapy will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1868631